Paul Hyman is part of the panel discussion on “Exploring Continuing Legal and Regulatory Conundrums Associated with the Monograph System and the OTC Drug Review Process: A call and Case for Modernization” at ACI’s Legal, Regulatory and Compliance Forum on Over the Counter Drugs. The …